Stay updated on the progress of our pioneering endeavors.
On June 19, Sinclair Aesthetics (“Sinclair”) hosted a new product launch at the Shangri-La Hotel in Shanghai, featuring the debut of the second generation of ELLANSÉ® products, the “Regenerative Haute Series”, which included ELLANSÉ® Zhenyan™, ELLANSÉ® Jinyan™…
Grandpharma (China) Co., Ltd. (00512.HK) (hereinafter referred to as Grand Pharma) participated in the 5th World Health Expo (hereinafter referred to as the Health Expo) with heavy products on April 7th. At the Health Expo, a series of innovative medical products were unveiled, such as Yttrium-90…
On November 3rd, the Ministry of Industry and Information Technology of China announced the list of National Technology Innovation Demonstration Enterprises for 2022. Grand Pharmaceuticals (China) Co., Ltd. (hereinafter referred to as “Grand Pharma”) was honored and…
On September 3, 2022, Beijing Grand Johamu Pharmaceutical Co., Ltd, one member enterprise in the respiratory and anti-severe-infection plate owned by Grand Pharma Group Co., Ltd. (0512.HK) (briefly known as Grand Pharma), held a product launch event for two globally innovative…
On August 19, 2022, the opening ceremony of Grand Pharma Wuhan Optics Valley R&D Center (“the Center”) and Extensive Intervention Production and R&D Platform (“the Platform”) was held at Donghu High-tech District Precision Medicine Industry Base…
On June 19, 2022, Grandpharma (0512.HK) announced that a "nuclear weapon" innovative medical product to treat liver malignant tumors -- SIR-Spheres® yttrium-90 microsphere injections (trademark in Chinese charters: 易甘泰®, read as “Yigantai”) …